Twist Bioscience (TWST) Inventory Average (2018 - 2026)

Twist Bioscience has disclosed Inventory Average across 9 years of filings, most recently posting $33.2 million for Q1 2026.

• In Q1 2026, Inventory Average rose 49.71% year-over-year to $33.2 million; the TTM figure through Mar 2026 stood at $33.2 million (up 49.71% YoY), while the FY2025 annual figure was $26.2 million, down 6.69% from the prior year.
• Inventory Average improved to $33.2 million in Q1 2026, from $30.6 million in the prior quarter.
• Over the last five years, Inventory Average for TWST reached as high as $43.8 million in Q2 2022 and fell as low as $22.2 million in Q1 2025.
• The 5-year median for Inventory Average is $31.5 million (2023), against an average of $33.1 million.
• Annual changes were most pronounced in 2022 — Inventory Average soared 190.05% — and 2024, when it dropped 27.54%.
• A 5-year view of Inventory Average shows it stood at $42.0 million in 2022, then dropped by 25.0% to $31.5 million in 2023, then dropped by 24.36% to $23.8 million in 2024, then rose by 28.65% to $30.6 million in 2025, then gained by 8.5% to $33.2 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $33.2 million, $30.6 million, and $27.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.